LEADER 01349oam  2200397   450 
001 9910707485903321
005 20221205105839.0
035   $a(CKB)5470000002464666
035   $a(OCoLC)956451955
035   $a(OCoLC)995470000002464666
035   $a(EXLCZ)995470000002464666
100   $a20160810d2008      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 14$aThe Food and Drug Administration's generic drug review process
210  1$a[Washington, D.C.] :$cDepartment of Health and Human Services, Office of Inspector General,$d2008.
215   $a1 online resource (iii, 36 pages) $cillustrations
300   $aTitle from title screen (viewed Aug 9, 2016).
300   $a"June 2008."
300   $a"OEI-04-07-00280."
320   $aIncludes bibliographical references.
517 1 $aFood and Drug Administration's generic drug review process
606   $aGeneric drugs$xGovernment policy$zUnited States
606   $aDrugs$zUnited States$xTesting
615  0$aGeneric drugs$xGovernment policy
615  0$aDrugs$xTesting.
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910707485903321
996   $aThe Food and Drug Administration's generic drug review process$93542625
997   $aUNINA